VE-PTP controls blood vessel development by balancing Tie-2 activity

Journal of Cell Biology

Volumn 185, Issue 4, 2009, Pages 657-671

  Winderlich, Mark ^a   Keller, Linda ^a   Cagna, Giuseppe ^a   Broermann, Andre ^a   Kamenyeva, Olena ^a   Kiefer, Friedemann ^a   Deutsch, Urban ^b   Nottebaum, Astrid F ^a   Vestweber, Dietmar ^a  

^a MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASCULAR ENDOTHELIAL PROTEIN TYROSINE KINASE ANTIBODY; VASCULAR ENDOTHELIAL PROTEIN TYROSINE PHOSPHATASE;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; ENDOCYTOSIS; ENDOTHELIUM CELL; EXPLANT; FETUS MEMBRANE; GENE DISRUPTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY;

ANIMALS; ANTIGENS, CD; BLOOD VESSELS; CADHERINS; CELL PROLIFERATION; CELLS, CULTURED; EMBRYO, MAMMALIAN; ENDOTHELIUM, VASCULAR; HUMANS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 3; RECEPTOR, TIE-2; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 3;

MUS;

EID: 66149094158     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200811159     Document Type: Article

References (42)

1. Baumeister, U., R. Funke, K. Ebnet, H. Vorschmitt, S. Koch, and D. Vestweber. 2005. Association of Csk to VE-cadherin and inhibition of cell proliferation. EMBO J. 24:1686-1695. (Pubitemid 40704979)
2. Baumer, S., L. Keller, A. Holtmann, R. Funke, B. August, A. Gamp, H. Wolburg, K. Wolburg-Buchholz, U. Deutsch, and D. Vestweber. 2006. Vascular endothelial cell specific phospho-tyrosine phosphatase (VE-PTP) activity is required for blood vessel development. Blood. 107:4754-4762. (Pubitemid 43882626)
3. Brindle, N.P., P. Saharinen, and K. Alitalo. 2006. Signaling and functions of angiopoietin-1 in vascular protection. Circ. Res. 98:1014-1023. (Pubitemid 43755222)
4. Cho, C.H., K.E. Kim, J. Byun, H.S. Jang, D.K. Kim, P. Baluk, F. Baffert, G.M. Lee, N. Mochizuki, J. Kim, et al. 2005. Long-term and sustained COMP-Ang1 induces long-lasting vascular enlargement and enhanced blood flow. Circ. Res. 97:86-94. (Pubitemid 40982326)
5. Davis, S., T.H. Aldrich, P.F. Jones, A. Acheson, D.L. Compton, V. Jain, T.E. Ryan, J. Bruno, C. Radziejewski, P.C. Maisonpierre, and G.D. Yancopoulos. 1996. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell. 87:1161-1169. (Pubitemid 27010100)
6. Dominguez, M.G., V.C. Hughes, L. Pan, M. Simmons, C. Daly, K. Anderson, I. Noguera-Troise, A.J. Murphy, D.M. Valenzuela, S. Davis, et al. 2007. Vascular endothelial tyrosine phosphatase (VE-PTP)-null mice undergo vasculogenesis but die embryonically because of defects in angiogenesis. Proc. Natl. Acad. Sci. USA. 104:3243-3248. (Pubitemid 46364144)
7. Drake, C.J., and P.A. Fleming. 2000. Vasculogenesis in the day 6.5 to 9.5 mouse embryo. Blood. 95:1671-1679. (Pubitemid 30120828)
8. Dumont, D.J., G. Gradwohl, G.H. Fong, M.C. Puri, M. Gertsenstein, A. Auerbach, and M.L. Breitman. 1994. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 8:1897-1909. (Pubitemid 24273890)
9. Eklund, L., and B.R. Olsen. 2006. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp. Cell Res. 312:630-641. (Pubitemid 43290339)
10. Fachinger, G., U. Deutsch, and W. Risau. 1999. Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2. Oncogene. 18:5948-5953. (Pubitemid 29520451)
11. Fujikawa, K., I. de Aos Scherpenseel, S.K. Jain, E. Presman, R.A. Christensen, and L. Varticovski. 1999. Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells. Exp. Cell Res. 253:663-672. (Pubitemid 30003127)
12. Gale, N.W., G. Thurston, S.F. Hackett, R. Renard, Q. Wang, J. McClain, C.B. Martin, C. Witte, M.H. Witte, D. Jackson, et al. 2002. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev. Cell. 3:411-423.
13. Gotsch, U., E. Borges, R. Bosse, E. Böggemeyer, M. Simon, H. Mossmann, and D. Vestweber. 1997. VE-cadherin antibody accelerates neutrophil recruitment in vivo. J. Cell Sci. 110:583-588. (Pubitemid 27153972)
14. Jones N, S.H. Chen, C. Sturk, Z. Master, J. Tran, R.S. Kerbel, and D.J. Dumont. 2003. A unique autophosphorylation site on Tie2/Tek mediates Dok-R phosphotyrosine binding domain binding and function. Mol. Cell. Biol. 23:2658-2668. (Pubitemid 36403068)
15. Kanda, S., Y. Miyata, Y. Mochizuki, T. Matsuyama, and H. Kanetake. 2005. Angiopoietin 1 is mitogenic for cultured endothelial cells. Cancer Res. 65:6820-6827. (Pubitemid 41060720)
16. Kim, K.E., C.H. Cho, H.Z. Kim, P. Baluk, D.M. McDonald, and G.Y. Koh. 2007. In vivo actions of angiopoietins on quiescent and remodeling blood and lymphatic vessels in mouse airways and skin. Arterioscler. Thromb. Vasc. Biol. 27:564-570. (Pubitemid 46263401)
17. Koblizek, T.I., A.S. Runting, S.A. Stacker, A.F. Wilks, W. Risau, and U. Deutsch. 1997. Tie2 receptor expression and phosphorylation in cultured cells and mouse tissues. Eur. J. Biochem. 244:774-779. (Pubitemid 27130513)
18. Koblizek, T.I., C. Weiss, G.D. Yancopoulos, U. Deutsch, and W. Risau. 1998. Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr. Biol. 8:529-532. (Pubitemid 28203073)
19. LaRue, A.C., V.A. Mironov, W.S. Argraves, A. Czirók, P.A. Fleming, and C.J. Drake. 2003. Patterning of embryonic blood vessels. Dev. Dyn. 228:21-29. (Pubitemid 37064840)
20. Maisonpierre, P.C., C. Suri, P.F. Jones, S. Bartunkova, S.J. Wiegand, C. Radziejewski, D. Compton, J. Mc, T.H. Clain, N. Aldrich, et al. 1997. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 277:55-60. (Pubitemid 27450643)
21. Murray, B.W., E.S. Padrique, C. Pinko, and M.A. McTigue. 2001. Mechanistic effects of autophosphorylation on receptor tyrosine kinase catalysis: enzymatic characterization of Tie2 and phospho-Tie2. Biochemistry. 40:10243-10253. (Pubitemid 32800131)
22. Nasdala, I., K. Wolburg-Buchholz, H. Wolburg, A. Kuhn, K. Ebnet, G. Brachtendorf, U. Samulowitz, B. Kuster, B. Engelhardt, D. Vestweber, and S. Butz. 2002. A transmembrane tight junction protein selectively expressed on endothelial cells and platelets. J. Biol. Chem. 277:16294-16303.
23. Nawroth, R., G. Poell, A. Ranft, U. Samulowitz, G. Fachinger, M. Golding, D.T. Shima, U. Deutsch, and D. Vestweber. 2002. VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. EMBO J. 21:4885-4895.
24. Nottebaum, A.F., G. Cagna, M. Winderlich, A.C. Gamp, R. Linnepe, C. Polaschegg, K. Filippova, R. Lyck, B. Engelhardt, O. Kamenyeva, et al. 2008. VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF. J. Exp. Med. 205:2929-2945.
25. Reiss, Y., and F. Kiefer. 2004. Immortalization of endothelial cells. In Methods in Endothelial Cell Biology. H.G. Augustin, editor. Springer, Berlin, Heidelberg, New York. 63-72.
26. Reiss, Y., G. Hoch, U. Deutsch, and B. Engelhardt. 1998. T cell interaction with ICAM-1-deficient endothelium in vitro: essential role for ICAM-1 and ICAM-2 in transendothelial migration of T cells. Eur. J. Immunol. 28:3086-3099. (Pubitemid 28470254)
27. Rodriguez, F., A. Vacaru, J. Overvoorde, and J. den Hertog. 2008. The receptor protein-tyrosine phosphatase, Dep1, acts in arterial/venous cell fate decisions in zebrafish development. Dev. Biol. 324:122-130.
28. Saharinen, P., K. Kerkela, N. Ekman, M. Marron, N. Brindle, G.M. Lee, H. Augustin, G.Y. Koh, and K. Alitalo. 2005. Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2. J. Cell Biol. 169:239-243. (Pubitemid 40656562)
29. Saharinen, P., L. Eklund, J. Miettinen, R. Wirkkala, A. Anisimov, M. Winderlich, A. Nottebaum, D. Vestweber, U. Deutsch, G.Y. Koh, et al. 2008. Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat. Cell Biol. 10:527-537.
30. Sato, T.N., Y. Tozawa, U. Deutsch, K. Wolburg-Buchholz, Y. Fujiwara, M. Gendron-Maguire, T. Gridley, H. Wolburg, W. Risau, and Y. Qin. 1995. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature. 376:70-74.
31. Shewchuk, L.M., A.M. Hassell, B. Ellis, W.D. Holmes, R. Davis, E.L. Horne, S.H. Kadwell, D.D. McKee, and J.T. Moore. 2000. Structure of the Tie2 RTK domain: self-inhibition by the nucleotide binding loop, activation loop, and C-terminal tail. Structure. 8:1105-1113. (Pubitemid 32667476)
32. Shim, W.S., I.A. Ho, and P.E. Wong. 2007. Angiopoietin: a TIE(d) balance in tumor angiogenesis. Mol. Cancer Res. 5:655-665.
33. Suri, C., P.F. Jones, S. Patan, S. Bartunkova, P.C. Maisonpierre, S. Davis, T.N. Sato, and G.D. Yancopoulos. 1996. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 87:1171-1180. (Pubitemid 27010101)
34. Takahashi, T., K. Takahashi, P.L. St John, P.A. Fleming, T. Tomemori, T. Watanabe, D.R. Abrahamson, C.J. Drake, T. Shirasawa, and T.O. Daniel. 2003. A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development. Mol. Cell. Biol. 23:1817-1831. (Pubitemid 36246061)
35. Teichert-Kuliszewska, K., P.C. Maisonpierre, N. Jones, A.I. Campbell, Z. Master, M.P. Bendeck, K. Alitalo, D.J. Dumont, G.D. Yancopoulos, and D.J. Stewart. 2001. Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovasc. Res. 49:659-670. (Pubitemid 32146429)
36. Thurston, G., Q. Wang, F. Baffert, J. Rudge, N. Papadopoulos, D. Jean-Guillaume, S. Wiegand, G.D. Yancopoulos, and D.M. McDonald. 2005. Angiopoietin 1 causes vessel enlargement, without angiogenic sprouting, during a critical developmental period. Development. 132:3317-3326. (Pubitemid 41167158)
37. Trapasso, F., A. Drusco, S. Costinean, H. Alder, R.I. Aqeilan, R. Iuliano, E. Gaudio, C. Raso, N. Zanesi, C.M. Croce, and A. Fusco. 2006. Genetic ablation of Ptprj, a mouse cancer susceptibility gene, results in normal growth and development and does not predispose to spontaneous tumorigenesis. DNA Cell Biol. 25:376-382. (Pubitemid 43954568)
38. Vikkula, M., L.M. Boon, K.L. Carraway, J.T. Calvert, A.J. Diamonti, B. Goumnerov, K.A. Pasyk, D.A. Marchuk, M.L. Warman, L.C. Cantley, et al. 1996. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell. 87:1181-1190. (Pubitemid 27010102)
39. Wegmann, F., J. Petri, A.G. Khandoga, C. Moser, A. Khandoga, S. Volkery, H. Li, I. Nasdala, O. Brandau, R. Fässler, et al. 2006. ESAM supports neutrophil extravasation, activation of Rho and VEGF-induced vascular permeability. J. Exp. Med. 203:1671-1677. (Pubitemid 44036272)
40. Witzenbichler, B., P.C. Maisonpierre, P. Jones, G.D. Yancopoulos, and J.M. Isner. 1998. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J. Biol. Chem. 273:18514-18521. (Pubitemid 28334780)
41. Yuan, H.T., S. Venkatesha, B. Chan, U. Deutsch, T. Mammoto, V.P. Sukhatme, A.S. Woolf, and S.A. Karumanchi. 2007. Activation of the orphan endothelial receptor Tie1 modifies Tie2-mediated intracellular signaling and cell survival. FASEB J. 21:3171-3183. (Pubitemid 47565536)
42. Zhu, J.W., T. Brdicka, T.R. Katsumoto, J. Lin, and A. Weiss. 2008. Structurally distinct phosphatases CD45 and CD148 both regulate B cell and macrophage immunoreceptor signaling. Immunity. 28:183-196.